Figure 2

Incidence of GI-related adverse events and adverse drug reactions stratified by evocalcet dose at the first onset. GI-related adverse events were defined as a combination of nausea, vomiting, abdominal discomfort, decreased appetite, and abdominal distension. Abbreviation: GI, gastrointestinal.